Home › Breast Cancer › NCT07478016

EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients

EXploring Inflammation and Social deTerminants (EXIST) Study in Breast Cancer Patients

Who can join

Ages 18 and older · Women

Inclusion Criteria:

* Individuals must meet all the following inclusion criteria to be eligible to participate in the study:

  1. Female
  2. \>18 years old at time of consent
  3. Biopsy proven invasive breast cancer or ductal carcinoma in situ
  4. Candidate has not yet received cancer therapy for their breast cancer diagnosis
  5. ECOG Performance Status \< 2
  6. Able to provide consent
  7. Must be English speaking

Exclusion Criteria:

* An individual who meets any of the following criteria will be excluded from participation in this study:

  1. Patient has started therapy or already had definitive oncologic surgery
  2. Another malignancy within the past 6 months that was not a non-melanomatous skin lesion

About the study

This is a pilot trial to assess how measures of inflammation are correlated with Social Determinants of Health (SDoH) in breast cancer patients. Expected duration of subject participation is one single time point. The patients will fill out questionnaires and provide a plasma sample.

What is being tested

• Survey Assessments (other)
• Diet Recall (other)
• Blood Biomarker Collection (other)

Sponsor: Thomas Jefferson University · Participants: 200 · Started: Dec 21, 2022

Contact the study team

• Nicole Simone, MD · Phone: 215-955-6702

Official record on ClinicalTrials.gov — NCT07478016

Locations in the U.S.

Conditions

• Breast Cancer
• Ductal Carcinoma In Situ (DCIS)

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.